{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:10:32Z","timestamp":1783350632259,"version":"3.54.6"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>We offer consensus recommendations for the antepartum management of the uterus transplant pregnancy based on our experience at 3 US centers. Patient access to accurate information is important to manage expectations and make informed decisions. Unique aspects of medical management include monitoring tacrolimus levels and performing cervical biopsies for rejection. Low-dose aspirin for preeclampsia is routinely used. Vigilant screening for gestational diabetes and preeclampsia allows for the prompt diagnosis and treatment of these common complications. We aim to deliver patients at 37 to 38 weeks by cesarean section. Shared decision making dominates whether to consider future pregnancies and timing of hysterectomy.<\/jats:p>","DOI":"10.1097\/grf.0000000000000682","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T20:00:38Z","timestamp":1642622438000},"page":"84-91","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Antepartum Care of the Uterus Transplant Patient: The Experience of 3 Successful US Centers"],"prefix":"10.1097","volume":"65","author":[{"given":"Uma C.","family":"Perni","sequence":"first","affiliation":[{"name":"Women\u2019s Health Institute, Division of Maternal-Fetal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen Y.","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"Gregg","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Prisma Health, Columbia, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s10815-021-02245-7","article-title":"Uterus transplantation: state of the art in 2021","volume":"38","author":"Richards","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/1471-0528.15863","article-title":"Human uterine transplantation: a review of outcomes from the first 45 cases","volume":"126","author":"Jones","year":"2019","journal-title":"BJOG"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/tog.12729","article-title":"Options for acquiring motherhood in absolute uterine factor infertility; adoption, surrogacy and uterine transplantation","volume":"23","author":"Jones","year":"2021","journal-title":"Obstet Gynaecol"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1111\/ajt.15973","article-title":"Guidelines for standardized nomenclature and reporting in uterus transplantation: an opinion from the United States Uterus Transplant Consortium","volume":"20","author":"Johannesson","year":"2020","journal-title":"Am J Transplant"},{"key":"R5-20250512","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/AOG.0000000000004244","article-title":"Twelve live births after uterus transplantation in the Dallas UtErus Transplant Study","volume":"137","author":"Johannesson","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R6-20250512","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajog.2020.03.001","article-title":"First birth from a deceased donor uterus in the United States: from severe graft rejection to successful cesarean delivery","volume":"223","author":"Flyckt","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20250512","first-page":"166","article-title":"Clinicopathologic analysis of uterine allografts including proposed scoring of ischemia-reperfusion injury and T cell-mediated rejection-Dallas UtErus Transplant Study: a pilot study","volume":"106","author":"Agarwal","year":"2021","journal-title":"Transplantation"},{"key":"R8-20250512","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/ajt.14135","article-title":"Monitoring of human uterus transplantation with cervical biopsies: a provisional scoring system for rejection","volume":"17","author":"Molne","year":"2017","journal-title":"Am J Transplant"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.15585\/mmwr.mm6439a3","article-title":"CDC grand rounds: understanding the causes of major birth defects\u2014steps to prevention","volume":"64","author":"Moore","year":"2015","journal-title":"Morb Mortal Wkly Rep"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"e13653","DOI":"10.1111\/tid.13653","article-title":"Pregnancy after CMV infection following uterus transplantation: a case report from the Dallas Uterus Transplant Study","volume":"23","author":"Rosenzweig","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.05.010","article-title":"Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012)","volume":"223","author":"Martins","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cpt.546","article-title":"Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus","volume":"101","author":"Chakkera","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"R13-20250512","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130770","article-title":"Tacrolimus- and sirolimus-induced human beta cell dysfunction is reversible and preventable","author":"Dai","year":"2020","journal-title":"JCI Insight"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/01.TP.0000157870.21957.E5","article-title":"Tacrolimus and posttransplant diabetes mellitus in renal transplantation","volume":"79","author":"van Hooff","year":"2005","journal-title":"Transplantation"},{"issue":"suppl 6","key":"R15-20250512","first-page":"vi1","article-title":"Post-transplant diabetes mellitus and renal function with tacrolimus: a decade of use, a decade of evidence. Foreword","volume":"19","author":"Vanrenterghem","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R16-20250512","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/AOG.0000000000002501","article-title":"ACOG Practice Bulletin No. 190: gestational diabetes mellitus","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R17-20250512","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jama.2021.11922","article-title":"Screening for gestational diabetes: US Preventive Services Task Force Recommendation Statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0002-9378(82)90349-0","article-title":"Criteria for screening tests for gestational diabetes","volume":"144","author":"Carpenter","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20250512","article-title":"Calcineurin in development and disease","author":"Chen","year":"2021","journal-title":"Genes Dis"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/TP.0000000000003578","article-title":"Uterine transplantation: review of livebirths and reproductive implications","volume":"105","author":"Jones","year":"2021","journal-title":"Transplantation"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/1471-0528.16685","article-title":"Decisions on second pregnancy after uterus transplantation and timing for removal of the uterus-DUETS (Dallas UtErus Transplant Study)","volume":"128","author":"Johannesson","year":"2021","journal-title":"BJOG"},{"key":"R23-20250512","article-title":"Neonatal outcomes after uterus transplantation: Dallas Uterus Transplant Study","author":"York","year":"2021","journal-title":"Am J Perinatol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:17:19Z","timestamp":1747063039000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000682","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,20]]}}}